title: [Cutaneous sarcomas: update on selected fibrohistiocytic and myofibroblastic tumors].
abstract: BACKGROUND
  Malignant fibrohistiocytic tumors are a heterogeneous group of mesenchymal neoplasms that may occur in the skin and subcutaneous tissues.
  
  
  METHODS
  Diagnosis of these tumors may be difficult, as they are rare, and a wide morphological diversity of types and subtypes has been described. In this update, relevant aspects of selected entities like dermatofibrosarcoma protuberans, desmoid tumor, atypical fibroxanthoma, pleomorphic dermal sarcoma, and myxofibrosarcoma are discussed according to the WHO classification of 2013. The typical clinical feature of these tumors is their mostly asymptomatic appearance. For diagnosis, the histologic workup is therefore the key feature; herein immunohistochemistry as well as molecular diagnostics become increasingly important.
  
  
  METHODS
  The primary treatment for locally resectable tumors is complete surgical removal; chemotherapy, radiation, and targeted therapies with kinase inhibitors are available for inoperable and metastatic disease.
authors.affiliation: Allgemeine Dermatologie, Medizinische Universität Graz, Auenbruggerplatz 8, 8036, Graz, Österreich.
authors.forename: B
authors.initials: B
authors.lastname: Aigner
authors.forename: S
authors.initials: S
authors.lastname: Ugurel
authors.forename: S
authors.initials: S
authors.lastname: Kaddu
authors.forename: J C
authors.initials: JC
authors.lastname: Becker
mesh_terms: D059248:Chemoradiotherapy / Q000379:methods*; D062109:Dermatologic Surgical Procedures / Q000379:methods*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012509:Sarcoma / Q000175:diagnosis / Q000628:therapy*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000628:therapy*
chemical_list: D047428:Protein Kinase Inhibitors